HawaiiSB 9672025–2026 Regular Session (Year 2)Senate

RELATING TO HEALTH.

Sponsored By: Kurt Fevella (Republican)

In Committee

Summary

Requires Medicaid and private insurance coverage for intravenous ketamine therapy to treat depression. Appropriates moneys.

Health InsuranceMedicaidMandated CoverageKetamine TherapyAppropriationsHHS, CPN/WAM

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kurt Fevella

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. The committee on HHS deferred the measure.

    2/6/2026Senate
  2. The committee(s) on HHS has scheduled a public hearing on 02-06-26 1:00PM; Conference Room 225 & Videoconference.

    2/3/2026Senate
  3. Carried over to 2026 Regular Session.

    12/8/2025
  4. Referred to HHS, CPN/WAM.

    1/23/2025Senate
  5. Passed First Reading.

    1/21/2025Senate
  6. Introduced.

    1/17/2025Senate

Bill Text

Related Bills

Back to State Legislation